πŸ‡ΊπŸ‡Έ FDA
Patent

US 8101766

Crystalline form of a biphenyl compound

granted A61PA61P11/00A61P11/06

Quick answer

US patent 8101766 (Crystalline form of a biphenyl compound) held by Theravance, Inc. expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P11/00, A61P11/06, A61P11/08, A61P35/00